title: What are the most promising emerging therapies for sickle cell disease?
authors: Laboratório de Pesquisa e Desenvolvimento de Fármacos, Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista-UNESP, Rodovia Araraquara Jaú Km 01, 14801-902, Araraquara, São Paulo, Brasil.
authors: Thais Regina
authors: TR
authors: Ferreira de Melo
authors: Chung Man
authors: CM
authors: Chin
authors: Jean Leandro
authors: JL
authors: dos Santos
mesh_terms: D000755:Anemia, Sickle Cell / Q000188:drug therapy* / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006918:Hydroxyurea / Q000378:metabolism / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism
chemical_list: D006454:Hemoglobins; D009569:Nitric Oxide; D006918:Hydroxyurea
keywords: fetal hemoglobin inducers; inflammation; new drugs; nitric oxide; sickle cell disease; vaso-occlusion